Years of discrimination have led to a scarcity of data on how hormone therapies affect cancer risk, and trans people who do get a cancer diagnosis often can’t find appropriate care.
The patch, thinner than a human hair and free of charge, measures your daily UV exposure.
Web browsing's ability to detect cancer and the reason storms are getting worse are among the 5 things we learned in Tech & Science this week.
Researchers at Columbia University and Microsoft discover novel method of predicting cancer.
Despite having a higher risk for cancer than the rest of the population, people with HIV are much less likely to get chemo, surgery and radiotherapy.
A claims the company’s talc-powder products caused her ovarian cancer, and in February a jury awarded $72 million to the family of a woman who died of ovarian cancer.
Researchers will be able to improve understanding and diagnoses of diseases such as cancer and dementia.
Research shows that nitrogen builds up in agricultural soils for decades and poses a longer-term threat than previously known.
A woman who used Baby Powder and Shower to Shower for feminine hygiene for more than 35 years was diagnosed three years ago with ovarian cancer.
Critics say Burzynski's cavalier attitude toward medical best practices has put the lives of thousands of patients at risk.
The president benefited from a breakthrough drug. New cancer drugs cost $200,000 for each additional year of life.
Preventing the human papillomavirus is critical for reducing rates of certain cancers, according to 69 of the nation’s leading clinical and research facilities.
New research finds certain types of the human papillomavirus make a person 22 times more likely to develop oropharyngeal cancer.
Patients with depression who were exposed to direct sunlight left the hospital four days quicker.
A new large-scale study suggests genetics play a role in more than 20 different types of cancer.
Degeneres has chosen to give the $200,000 donation associated with the People’s Choice “favorite humanitarian” award to St. Jude.